MLND MLND 深 沪
已收盘 06-25 16:00:00 美东时间
1.06
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.06
- 总市值 2018.56万
- 52周最高 540.15
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 179.01
- 委 比 0.00%
- 总股本 1904.30万
- 历史最高 3381.30
- 量 比 0
- 振 幅 0.00%
- 历史最低 179.01
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Moore Kuehn Encourages LEAF, MLND, LATN, And GNLN Investors To Contact Law Firm
NEW YORK,April 6, 2021/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in...
2021-04-06 14:39
Is MLND A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towar...
2020-12-11 05:26
Millendo Therapeutics to Participate in September Investor Conferences
Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical ...
2020-09-03 12:30
Millendo Therapeutics, Inc. (MLND): Hedge Funds Were Caught Flatfooted
At the end of February we announced the arrival of the first US recession since...
2020-07-02 21:09
Citigroup Reinstates Buy on Millendo Therapeutics, Announces $6 Price Target
This headline-only article is meant to show you why a stock is moving , the mos...
2020-05-29 09:00
Millendo Therapeutics Q1 EPS $(0.650) Up From $(0.780) YoY
Millendo Therapeutics (NASDAQ:MLND) reported quarterly losses of $(0.650) per s...
2020-05-08 20:33
终止开发！Millendo(MLND.US)罕见病新药IIb期研究失败
医药魔方 4月6日，Millendo Therapeutics(MLND.US)宣布因IIb期ZEPHYR研究失败，公司将终止其非酰化胃饥饿素类似物livol...
2020-04-07 19:06
Millendo Therapeutics EPS beats by $0.07
Millendo Therapeutics (NASDAQ:MLND): Q2 GAAP EPS of -$0.74 beats by $0.07. Cash...
2019-08-12 19:33
Millendo Therapeutics Inc盘中异动 大幅下挫5.40%
北京时间2019年08月02日02时18分，Millendo Therapeutics Inc（MLND.us）股票出现异动，股价大幅下跌5.40%。截至发稿...
2019-08-02 02:52
